Penalized Cox regression with a five-parameter spline model by Jia-Han Shih (4858300)

“…For analysis of right-censored data, we introduce a penalized Cox regression method using five M-spline basis functions. …”

DEC2 decreased sensitivity to DNA damage in hypoxic pre-conditioned cells. by Hideaki Nakamura (402108)

Integrating nutrient bioavailability and co-production links when identifying sustainable diets: How low should we reduce meat consumption? by Tangui Barré (4853530)

“…Starting from 36g/d women’s OBS diet (54g/d for men), ruminant meat quantity dropped severely by 84% and 87% in NE and NEB diets for women (80% and 78% for men), whereas it only decreased by 27% in NEB-CP diets (38% for men). The share of energy and proteins of animal origin was similar for the 3 modeled diets (approximately 1/5 of total energy, and 1/2 of protein) and lower than in OBS diet (approximately 1/3 of total energy, and 2/3 of protein).…”

Rpl22L1 promotes growth and anchorage-independence. by Shuyun Rao (449181)

Place preference as a function of <i>Gr5a</i>-receptor-neuron stimulation. by Sophie E. Seidenbecher (9454842)

“…<p>For optogenetic stimulation we used flies that express Chrimson in <i>Gr5a</i> neurons. …”

High expression of Rpl22L1 is correlated with poor survival in CRC. by Shuyun Rao (449181)

5-FU resistant CRC-PDX samples exhibit increased Rpl22L1 staining. by Shuyun Rao (449181)

Dataset: Response diversity increases functional but decreases compositional stability of grassland communities by Robert Junker (19802088)

Subcellular location and expression of Halo-zDHHC20 and Halo-zDHHC5 in Flp-In 293 T-REx cells. by Mingjie Bai (10028513)

Rpl22L1 regulates 5-FU responsiveness in CRC. by Shuyun Rao (449181)

Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 2. by Rahsan Erdem (11726357)

Subjects:

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Subjects: